Mark Germain Net Worth & Insider Trades

Mark Germain - Director, Pluristem Therapeutics Inc

As of September 10, 2020

What is Mark Germain's Net Worth?

The current estimated net worth of Pluristem Therapeutics Inc's Director, Mark Germain, is estimated to be about $622.67K . Mark Germain owns about 513,944 units of Pluristem Therapeutics Inc common stock. In the last 13 years at Pluristem Therapeutics Inc, Mark Germain has sold an estimated value of $511.2K worth.

What is Mark Germain's Past Insider Trading?

Mark Germain's largest sale order was 67,858 units , worth over $272.79K on March 5, 2014. In total, Mark Germain has made about 22 transactions over 13 years of their time at Pluristem Therapeutics Inc. Mark Germain usually trades in December, with the busiest year in 2009. The most recent transaction was a sale order of 45,873 units , worth over $67.89K on March 19, 2018.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...

InsideArbitrage

Our partner InsideArbitrage provides a full suite of tools and analysis that allows you to find opportunities from the hundreds of insiders transactions filed by company insiders each week. The service includes the popular Insider Weekends articles that highlight the top 5 insider purchases and sales each week as well as detailed analysis of one company each week. The service also includes several custom screens such as the Double Dipper that includes a list of companies that are buying back their shares while their insiders are independently buying stock on the open market for their own portfolios.

What is Mark Germain's' Mailing Address?

  • Mailing address is Wellsford Real Properties Inc 535 Madison Avenue New York NY 10022 NY

Pluristem Therapeutics Inc Executive Compensation

Name
Year
Salary
Other Earnings Plans or Compensations
Other Compensation
Total
Zami Aberman 2020 $439,704 - $61,540 $501,244
Zami Aberman 2019 $551,137 $478,500 $66,857 $1,096,494
Yaky Yanay 2020 $320,911 - $29,466 $350,377
Yaky Yanay 2019 $396,632 $461,100 $29,253 $886,985
Chen Franco-Yehuda 2020 $179,229 - $28,461 $207,690
Chen Franco-Yehuda 2019 $78,889 $112,329 $13,599 $204,817
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1158780/000121390021020786/ea139144-def14a_pluristem.htm

What are Pluristem Therapeutics Inc's Past Insider Trades?

Pluristem Therapeutics Inc's most recent insider trade came on February 14, 2022 by Zami Aberman who bought 80,616 units worth $145.11K . In the last 14 years, insiders at Pluristem Therapeutics Inc have sold an estimated value of $7.29M and bought an estimated value of $14.34M worth of shares. Insider trading is most common in December, with the busiest year in 2009. The most active traders at the company are Zami Aberman, Director,  Yaky Yanay, CEO & President,  and Israel Ben-Yoram, Director .

PAM TRANSPORTATION SERVICES INC Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...